Skip to main content
. 2020 Jan 17;43(3):953–964. doi: 10.3892/or.2020.7469

Figure 1.

Figure 1.

miR-29c-3p is downregulated in HCC. (A) The results of qRT-PCR revealed the expression level of miR-29c-3p in HCC and adjacent non-cancerous tissues (n=60). (B) Kaplan-Meier analysis of DSS between HCC patients with high and low miR-29c-3p expression. (C) Kaplan-Meier analysis of RFS between HCC patients with high and low miR-29c-3p expression. *P<0.05 compared to the control. HCC, hepatocellular carcinoma; DSS, disease-specific survival; RFS, recurrence-free survival.